Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

firstwordpharma.com
firstwordpharma.com > story > 7983565

AstraZeneca's oral SERD stumbles in Phase III first-line breast cancer trial

5+ hour, 4+ min ago   (12+ words) firstwordpharma.com...

FirstWord PHARMA
firstwordpharma.com > story > 7972962

AbbVie aims to expand Qulipta's label into new migraine market

2+ day, 11+ hour ago   (12+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7969518

NodThera rebrands as Rezera, charts registrational path for PAD drug

3+ day, 4+ hour ago   (12+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7966708

Physician Views Results: Neurologists express cautious optimism for BTK inhibitors in MS

3+ day, 22+ hour ago   (14+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7967798

Beeline buzzes ahead to pivotal lupus trials after mid-stage success

3+ day, 17+ hour ago   (12+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7966709

Tyra remains upbeat after oral bladder cancer drug misses study expectations

3+ day, 22+ hour ago   (13+ words) FirstWord Pharma...

FirstWord PHARMA
firstwordpharma.com > story > 7963831

AI analysis from Brainomix adds to evidence backing Endeavor's IPF therapy

4+ day, 14+ hour ago   (13+ words) FirstWord PHARMA...

FirstWord PHARMA
firstwordpharma.com > story > 7961783

Amgen claims win for Imdelltra in maintenance lung cancer setting

4+ day, 17+ hour ago   (12+ words) FirstWord PHARMA...

FirstWord Pharma
firstwordpharma.com > story > 7960381

Next-gen CAR-T from BMS passes pivotal test in quadruple-class exposed myeloma

4+ day, 22+ hour ago   (13+ words) FirstWord Pharma...

FirstWord Pharma
firstwordpharma.com > story > 7960102

Roivant's pulmonary hypertension drug mosliciguat scores mid-stage win

5+ day, 49+ min ago   (10+ words) FirstWord Pharma...